At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 8, 2026 at 16:06 ET
Bausch Health Companies Inc. filed a definitive proxy statement for its annual shareholder meeting, which includes details on director elections and executive compensation. The filing is routine and does not contain any material financial updates or strategic changes.
- Filing is a definitive proxy statement (DEFA14A) for an annual shareholder meeting
- Covers director elections and executive compensation
- No material financial information or strategic changes disclosed
- Routine filing with no immediate financial impact
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access